PR Newswire BiotechOriginal article
ImmunoForge Selected for the Ministry of SMEs and Startups' 'Global TIPS R&D' Program… "Expansion of the LMT Platform"
positiveLMT PlatformPositive
AI Analysis
Summary
ImmunoForge was selected for the Ministry of SMEs and Startups' Global TIPS R&D Program and won first place for its LMT platform combining leptin receptor-based technology with a hybrid LNP platform for CNS-targeted therapeutics with blood-brain barrier penetration and one-month sustained-release capability.
Outcome Details
Selected for Global TIPS R&D Program; won first place in validation
Importance:5/10
Sentiment:
0.70
CNSBlood-Brain BarrierLeptin receptorLNP platformSustained-releaseGovernment fundingTechnology validation
Read the original article
Published by PR Newswire Biotech on August 24, 2026 7:01 AM